Correlation Between Dynavax Technologies and TNF Pharmaceuticals,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and TNF Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and TNF Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and TNF Pharmaceuticals,, you can compare the effects of market volatilities on Dynavax Technologies and TNF Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of TNF Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and TNF Pharmaceuticals,.

Diversification Opportunities for Dynavax Technologies and TNF Pharmaceuticals,

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Dynavax and TNF is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and TNF Pharmaceuticals, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TNF Pharmaceuticals, and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with TNF Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TNF Pharmaceuticals, has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and TNF Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Dynavax Technologies and TNF Pharmaceuticals,

Given the investment horizon of 90 days Dynavax Technologies is expected to generate 3.02 times less return on investment than TNF Pharmaceuticals,. But when comparing it to its historical volatility, Dynavax Technologies is 10.64 times less risky than TNF Pharmaceuticals,. It trades about 0.1 of its potential returns per unit of risk. TNF Pharmaceuticals, is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  140.00  in TNF Pharmaceuticals, on September 24, 2024 and sell it today you would lose (4.00) from holding TNF Pharmaceuticals, or give up 2.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dynavax Technologies  vs.  TNF Pharmaceuticals,

 Performance 
       Timeline  
Dynavax Technologies 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dynavax Technologies showed solid returns over the last few months and may actually be approaching a breakup point.
TNF Pharmaceuticals, 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in TNF Pharmaceuticals, are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady technical and fundamental indicators, TNF Pharmaceuticals, sustained solid returns over the last few months and may actually be approaching a breakup point.

Dynavax Technologies and TNF Pharmaceuticals, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dynavax Technologies and TNF Pharmaceuticals,

The main advantage of trading using opposite Dynavax Technologies and TNF Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, TNF Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TNF Pharmaceuticals, will offset losses from the drop in TNF Pharmaceuticals,'s long position.
The idea behind Dynavax Technologies and TNF Pharmaceuticals, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing